PAVmed Inc - Asset Resilience Ratio
PAVmed Inc (PAVM) has an Asset Resilience Ratio of 1.57% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of PAVmed Inc to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how PAVmed Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see PAVM asset base.
Liquid Assets Composition Over Time
This chart breaks down PAVmed Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore PAVM long-term investment intensity to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $480.00K | 1.57% |
| Total Liquid Assets | $480.00K | 1.57% |
Asset Resilience Insights
- Limited Liquidity: PAVmed Inc maintains only 1.57% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
PAVmed Inc Industry Peers by Asset Resilience Ratio
Compare PAVmed Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Biosynex
PA:ALBIO |
Medical Devices | 3.35% |
Annual Asset Resilience Ratio for PAVmed Inc (2017–2024)
The table below shows the annual Asset Resilience Ratio data for PAVmed Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.13% | $347.00K | $30.66 Million | -6.94pp |
| 2023-12-31 | 8.07% | $2.67 Million | $33.12 Million | +2.50pp |
| 2022-12-31 | 5.57% | $3.00 Million | $53.98 Million | +3.28pp |
| 2021-12-31 | 2.29% | $1.99 Million | $86.98 Million | +0.96pp |
| 2020-12-31 | 1.32% | $262.00K | $19.78 Million | +0.86pp |
| 2019-12-31 | 0.47% | $34.00K | $7.24 Million | -0.05pp |
| 2018-12-31 | 0.52% | $44.25K | $8.50 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $1.64 Million | -- |
About PAVmed Inc
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing… Read more